Aerie Pharmaceuticals, Inc. Operating Lease Liability
Aerie Pharmaceuticals, Inc. had Operating Lease Liability of $26.12 million as of 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2022-02-25
- 2021-12-31: Operating Lease, Liability $26.12M.
- 2021-09-30: Operating Lease, Liability $26.43M.
- 2021-06-30: Operating Lease, Liability $13.92M.
- 2021-03-31: Operating Lease, Liability $13.97M.
| Period end | Operating Lease, Liability |
|---|---|
| 2021-12-31 | $26.12M 10-K · filed 2022-02-25 |
| 2021-09-30 | $26.43M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $13.92M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $13.97M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $15.13M 10-K · filed 2022-02-25 |
| 2020-09-30 | $16.06M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $15.81M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $16.44M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $17.60M 10-K · filed 2021-02-26 |
| 2019-09-30 | $18.04M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $18.73M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $17.08M 10-Q · filed 2019-05-08 |